Mycobacterium Tuberculosis-Specific Memory NKT Cells in Patients with Tuberculous Pleurisy

Journal of Clinical Immunology

Volumn 34, Issue 8, 2014, Pages 979-990

  Li, Zitao ^a   Yang, Binyan ^a   Zhang, Yannan ^a   Ma, Jiangjun ^a   Chen, Xinchun ^b   Lao, Suihua ^c   Li, Baiqing ^d   Wu, Changyou ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^c Chest Hospital of Guangzhou   (China)

^d BENGBU MEDICAL COLLEGE   (China)

Author keywords

Cytokines; memory; NKT cells; PPD; tuberculosis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PERFORIN; PROTEIN; WORTMANNIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CD25+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD69+ T LYMPHOCYTE; CELL SELECTION; CELL SPECIFICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLEURA FLUID; PROTEIN EXPRESSION; T LYMPHOCYTE; TUBERCULOUS PLEURISY; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T-CELLS; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; TUBERCULOSIS, PLEURAL;

EID: 84911961060     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0090-8     Document Type: Article

References (40)

1. World Health Organization. Global tuberculosis report. 2012.
2. Ahmad S. New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res. 2010;11:169.
3. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA. 1999;282(7):677–86.
4. Landry J, Menzies D. Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis. 2008;12(12):1352–64.
5. Kaufmann SH. Tuberculosis: back on the immunologists’ agenda. Immunity. 2006;24(4):351–7.
6. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM. Innate invariant NKT cells recognize mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog. 2008;4(12):e1000239.
7. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what’s in a name? Nat Rev Immunol. 2004;4(3):231–7.
8. Van Kaer L. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol. 2005;5(1):31–42.
9. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest. 2004;114(10):1379–88.
10. Wermeling F, Lind SM, Jordö ED, Cardell SL, Karlsson MC. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J Exp Med. 2010;207(5):943–52.
11. Montoya CJ, Cataño JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL. Invariant NKT cells from HIV-1 or mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008;127(1):1–6.
12. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745–63.
13. + NKT cell in PBMC. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27(9):949–53.
14. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11(2):131–42.
15. Sutherland JS, Jeffries DJ, Donkor S, Walther B, Hill PC, Adetifa IM, et al. High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis (Edinb). 2009;89(6):398–404.
16. Chackerian A, Alt J, Perera V, Behar SM. Activation of NKT cells protects mice from tuberculosis. Infect Immun. 2002;70(11):6302–9.
17. Gansert JL, Kiessler V, Engele M, Wittke F, Röllinghoff M, Krensky AM, et al. Human NKT cells express granulysin and exhibit antimycobacterial activity. J Immunol. 2003;170(6):3154–61.
18. Sada-Ovalle I, Sköld M, Tian T, Besra GS, Behar SM. Alpha-galactosylceramide as a therapeutic agent for pulmonary mycobacterium tuberculosis infection. Am J Respir Crit Care Med. 2010;182(6):841–7.
19. Venkataswamy MM, Baena A, Goldberg MF, Bricard G, Im JS, Chan J, et al. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J Immunol. 2009;183(3):1644–56.
20. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to mycobacterium tuberculosis infection. J Exp Med. 1993;178(6):2249–54.
21. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335(26):1941–9.
22. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996;335(26):1956–61.
23. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondanèche MC, Tuerlinckx D, Blanche S, et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest. 1997;100(11):2658–64.
24. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest. 2002;110(6):793–800.
25. Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, et al. Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients. Leukemia. 2010;24(3):592–600.
26. Lucas M, Gadola S, Meier U, Young NT, Harcourt G, Karadimitris A, et al. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection. J Virol. 2003;77(3):2251–7.
27. van der Vliet HJ, Molling JW, von Blomberg BM, Kölgen W, Stam AG, de Gruijl TD, et al. Circulating Valpha24 + Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. Clin Immunol. 2005;114(2):183–9.
28. Ward SM, Jonsson JR, Sierro S, Clouston AD, Lucas M, Vargas AL, et al. Virus-specific CD8+ T lymphocytes within the normal human liver. Eur J Immunol. 2004;34(6):1526–31.
29. Baev DV, Peng XH, Song L, Barnhart JR, Crooks GM, Weinberg KI, et al. Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. Blood. 2004;104(13):4150–6.
30. Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol. 2005;35(5):1399–407.
31. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest. 2001;108(9):1331–9.
32. Fujiwara H, Tsuyuguchi I. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. Chest. 1986;89(4):530–2.
33. Barnes PF, Fong SJ, Brennan PJ, Twomey PE, Mazumder A, Modlin RL. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol. 1990;145(1):149–54.
34. Li L, Qiao D, Fu X, Lao S, Zhang X, Wu C. Identification of M. tuberculosis-specific Th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy. PLoS One. 2011;6(8):e23700.
35. Li L, Qiao D, Fu X, Lao S, Zhang X, Wu C. Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy. PLoS One. 2011;6(5):e20165.
36. Li L, Qiao D, Zhang X, Liu Z, Wu C. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD + donors were modulated by Treg cells. Immunobiology. 2011;216(4):477–84.
37. + T cells in tubercular pleural fluid, with biased usage of T cell receptor Vβ chains. Infect Immun. 2011;79(8):3358–65.
38. Feng L, Li L, Liu Y, Qiao D, Li Q, Fu X, et al. B lymphocytes that migrate to tuberculous pleural fluid via the SDF-1/CXCR4 axis actively respond to antigens specific for Mycobacterium tuberculosis. Eur J Immunol. 2011;41(11):3261–9.
39. Wu SH, Chu JJ, Chiang CD. Increased soluble Fas ligand concentration in tuberculous pleural effusion. J Formos Med Assoc. 2001;100(1):32–4.
40. Fayyazi A, Eichmeyer B, Soruri A, Schweyer S, Herms J, Schwarz P, et al. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J Pathol. 2000;191(4):417–25.